Homocysteine and Pregnancy: Research Review

While pregnant, a person’s risk for blood clots in their veins (venous thromboembolism) increases 5- to 6-fold. Homocysteine is a metabolic by-product. High homocysteine levels (hyperhomocysteinemia) can indicate a vitamin B12, B6, or folate deficiency, and is a risk factor for thrombosis and cardiovascular disease as well as adverse pregnancy outcomes.

Physiology

MTHFR (5, 10 methylenetetrahydrofolate reductase) is one of the key enzymes involved in folic acid metabolism and is directly responsible for homocysteine conversion to methionine (figure below). Folate and methionine are essential for nucleic acid synthesis (component of your DNA) and are required for methylation reactions.

Normal MTHFR activity is crucial to maintain normal levels of circulating folate and methionine and is key to prevent the accumulation of homocysteine.

Hyperhomocysteinemia is observed in approximately 5% of the general population and is associated with increased risk for many inflammatory disorders including auto immune disorders (Rheumatoid Arthritis, Diabetes, Multiple Sclerosis, Systemic Lupus erythematosus, Grave disease), birth defects and adverse pregnancy outcomes (pre-eclampsia, placental abruption, spontaneous abortion, low birth weight), as well as vascular and neurodegenerative diseases. Homocysteine is at the epicenter of oxidative stress and DNA methylation errors.

Published clinical data

Elevated serum homocysteine concentration is an important problem causing birth defects¹, pre-eclampsia^2-4, placental abruption², low birth weight and other maternal or fetal complications⁵.